Last reviewed · How we verify
DN1508052-01
At a glance
| Generic name | DN1508052-01 |
|---|
| Sponsor | Shanghai De Novo Pharmatech Co., Ltd. |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.